2024 Egyptian consensus statement on the role of non-statin therapies for LDL cholesterol lowering in different patient risk categories
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
2024 Egyptian consensus statement on the role of non-statin therapies for LDL cholesterol lowering in different patient risk categories ; volume:76 ; number:1 ; day:20 ; month:9 ; year:2024 ; pages:1-14 ; date:12.2024
The Egyptian heart journal ; 76, Heft 1 (20.9.2024), 1-14, 12.2024
- Creator
-
El Din Taha, Hesham Salah
Kandil, Hossam
Badran, Hala Mahfouz
Farag, Nabil
Khamis, Hazem
Nasr, Gamila
Samy, Mina
Abdrabou, Moustafa
Abuelezz, Mohamed
Shaker, Mirna Mamdouh
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43044-024-00562-7
- URN
-
urn:nbn:de:101:1-2412032126377.748657244676
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- El Din Taha, Hesham Salah
- Kandil, Hossam
- Badran, Hala Mahfouz
- Farag, Nabil
- Khamis, Hazem
- Nasr, Gamila
- Samy, Mina
- Abdrabou, Moustafa
- Abuelezz, Mohamed
- Shaker, Mirna Mamdouh
- SpringerLink (Online service)
Other Objects (12)
Short-term LDL cholesterol-lowering efficacy of plant stanol esters
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation
Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9
Dose-dependent LDL-cholesterol lowering effect by plant stanol ester consumption: clinical evidence
Cholesterol-Lowering Super juice
Overcoming therapeutic inertia in LDL cholesterol-lowering treatment with education and simplified treatment algorithms
Quo vadis, LDL cholesterol?
Differential influences of LDL cholesterol on functional outcomes after intravenous thrombolysis according to prestroke statin use
Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Non-statin lipid-lowering therapy over time in very-high-risk patients: effectiveness of fixed-dose statin/ezetimibe compared to separate pill combination on LDL-C
Short-term LDL cholesterol-lowering efficacy of plant stanol esters
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation
Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9
Dose-dependent LDL-cholesterol lowering effect by plant stanol ester consumption: clinical evidence
Cholesterol-Lowering Super juice
Overcoming therapeutic inertia in LDL cholesterol-lowering treatment with education and simplified treatment algorithms
Quo vadis, LDL cholesterol?
Differential influences of LDL cholesterol on functional outcomes after intravenous thrombolysis according to prestroke statin use
Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Non-statin lipid-lowering therapy over time in very-high-risk patients: effectiveness of fixed-dose statin/ezetimibe compared to separate pill combination on LDL-C
Short-term LDL cholesterol-lowering efficacy of plant stanol esters
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation
Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9
Dose-dependent LDL-cholesterol lowering effect by plant stanol ester consumption: clinical evidence
Cholesterol-Lowering Super juice
Overcoming therapeutic inertia in LDL cholesterol-lowering treatment with education and simplified treatment algorithms
Quo vadis, LDL cholesterol?
Differential influences of LDL cholesterol on functional outcomes after intravenous thrombolysis according to prestroke statin use
Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events
Glycaemic Effects of Non-statin Lipid-Lowering Therapies